SCHEMBL19785143

SCHEMBL19785143

CC(=O)C(C)NS(=O)(=O)c1ccc(Br)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 11/20 0.69
MMP1 P03956 8/20 0.69
MMP9 P14780 8/20 0.69
MMP13 P45452 8/20 0.69
MMP3 P08254 7/20 0.69
MMP7 P09237 7/20 0.69
MMP14 P50281 1/20 0.57
CA12 O43570 1/20 0.54
CA9 Q16790 1/20 0.54
CA14 Q9ULX7 1/20 0.54
SLC1A3 P43003 1/20 0.53
SLC1A2 P43004 1/20 0.53
SLC1A1 P43005 1/20 0.53
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
MMP8 P22894 1/20 0.52
ADAMTS4 O75173 1/20 0.51
ALDH1A1 P00352 1/20 0.51
GAA P10253 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7414131 0.85 MMP2 (0.68) MMP2MMP1MMP9MMP13MMP3
SCHEMBL19000605 0.84 TSHR (0.61) MMP2MMP1MMP9MMP13MMP3
SCHEMBL13890464 0.83 MMP2 (0.57) MMP2MMP1MMP9MMP13MMP3
SCHEMBL7407715 0.82 MMP2 (1.00) MMP2MMP1MMP9MMP13MMP3
SCHEMBL7407707 0.82 MMP2 (1.00) MMP2MMP1MMP9MMP13MMP3
SCHEMBL14191408 0.80 MMP2 (0.74) MMP2MMP1MMP9MMP13MMP3
SCHEMBL3017227 0.80 MMP2 (0.60) MMP2MMP1MMP9MMP13MMP3
SCHEMBL8445730 0.79 MMP2 (0.59) MMP2MMP1MMP9MMP13MMP3
SCHEMBL1684446 0.78 DHFR (0.67) MMP2MMP1MMP9MMP13MMP3
SCHEMBL3412101 0.77 MMP2 (0.58) MMP2MMP1MMP9MMP13MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018011163-A1 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE AND 6,7-DIHYDRO-4H-TRIAZOLO[1,5-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2018-01-18 WO disclosed